Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
Zacks Equity Research, 07 December 2020
Launched on 12/20/2011, the VanEck Vectors Pharmaceutical ETF (PPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare – Pharma segment of the equity market.
Retail and institutional investors increasingly turn to passively managed ETFs because they offer low costs, transparency, flexibility, and tax efficiency; these kind of funds are also excellent vehicles for long term investors. Continue reading “Article: Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?”
